Alembic Pharmaceuticals Ltd.
| BSE: 533573 | Sector: Health care |
| NSE: APLLTD | ISIN Code: INE901L01018 |
| BSE 00:00 | 26 Apr | 519.65 |
1.40 (0.27%) |
OPEN
510.55 |
HIGH
521.90 |
LOW
510.55 |
| NSE 00:00 | 26 Apr | 520.00 |
0 (0.00%) |
OPEN
514.00 |
HIGH
521.90 |
LOW
514.00 |
| OPEN | 510.55 |
| PREVIOUS CLOSE | 518.25 |
| VOLUME | 1904 |
| 52-Week high | 630.00 |
| 52-Week low | 469.75 |
| P/E | 29.06 |
| Mkt Cap.(Rs cr) | 9,795 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alembic Pharmaceuticals Ltd. (APLLTD) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Lupin | 795.25 | -17.15 | -2.11 | 3141.33 |
| Glenmark Pharma. | 566.95 | 1.60 | 0.28 | 2140.61 |
| Aurobindo Pharma | 628.30 | 4.40 | 0.71 | 1706.76 |
| Dr Reddy's Labs | 2080.40 | -44.35 | -2.09 | 1384.10 |
| Divi's Lab. | 1172.40 | 11.65 | 1.00 | 1053.27 |
| Cipla | 599.85 | 5.65 | 0.95 | 974.94 |
| Alkem Lab | 1915.15 | -24.25 | -1.25 | 883.16 |
| Torrent Pharma. | 1393.65 | -2.25 | -0.16 | 854.22 |
| Piramal Enterp. | 2585.10 | 7.30 | 0.28 | 776.78 |
| Cadila Health. | 409.35 | 7.15 | 1.78 | 661.90 |
| Biocon | 663.25 | 9.45 | 1.45 | 519.30 |
| Ajanta Pharma | 1364.30 | 8.20 | 0.60 | 499.81 |
| Natco Pharma | 816.65 | -2.50 | -0.31 | 494.80 |
| Alembic Pharma | 519.65 | 1.40 | 0.27 | 430.63 |
| Glaxosmi. Pharma | 2324.10 | -19.00 | -0.81 | 336.78 |
| Pfizer | 2190.65 | -17.85 | -0.81 | 336.78 |
| Sanofi India | 4850.15 | -110.75 | -2.23 | 326.00 |
| Syngene Intl. | 642.40 | -33.85 | -5.01 | 287.30 |
| Apollo Hospitals | 1080.20 | -7.00 | -0.64 | 285.15 |
| Abbott India | 6086.95 | -105.25 | -1.70 | 276.65 |
Quick Links for Alembic Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
